We are

globally connected

Latin America Europe Asia Australia & New Zealand India Middle East Africa USA & Canada

Asia

China

Brunei China Hong Kong Indonesia Japan Cambodia Laos Macao Malaysia Mongolia Myanmar Philippines Singapore South Korea Taiwan Thailand Vietnam

Highlight matters China

Gleiss Lutz advises Sunshine Lake Pharma on its listing on Hong Kong Stock Exchange and privatisation of YiChang HEC Mandate
Gleiss Lutz advises CAC Nantong Chemical on acquisition of HELM’s chemical plant protection portfolio in Europe Mandate
Gleiss Lutz advises ruhlamat on sale of its China business to private equity investor Centurium Capital Mandate
Gleiss Lutz advises Sinochem on the Restructuring of the KraussMaffei Group Mandate
Gleiss Lutz advises Siemens on sale of wiring accessories business in China Mandate
Gleiss Lutz advises Hauck Aufhäuser Lampe on its sale to ABN AMRO Mandate
Gleiss Lutz advises Chinese investors on acquisition of majority stake in SPT Mandate
Gleiss Lutz advises Vesync in connection with its IPO on the Hong Kong Stock Exchange Mandate
Gleiss Lutz advises ASML on its acquisition of Berliner Glas Group Mandate
Gleiss Lutz advises Robert Bosch on the carve-out and sale of Bosch Packaging Technology to CVC Capital Partners Mandate
IFLR European Awards 2018: Gleiss Lutz wins in M&A Deal of the Year category Mandate
Gleiss Lutz advises Bosch and Mahle on the sale of their joint venture Bosch Mahle Turbo Systems (BMTS) Mandate
Deals of the Year 2016: China Business Law Journal honours ChemChina/Syngenta transaction Article
Gleiss Lutz advises STIHL on participation in the Globe Tools Group Mandate
Gleiss Lutz advises DMB Deutsche Mittelstand Beteiligungen on sale of WEGU to Zhongding Mandate
Contact persons China
Chambers Global 2024

“one of Germany's strongest independent practices, offering clients cross-border expertise and support across an array of areas”